Arvinas
arvinas.com
Actively hiring
Drug Discovery
Oncology Therapeutics
Prescription Drugs
As featured in
View 1 job
Claim pageClaim
Follow
Overview
News
Technologies
Salaries
Products
People
Growth
Offices
Jobs
Financials
News
Arvinas (ARVN) Just Made Protein Degrader History With FDA Nod
On August 4, Arvinas Inc. (NASDAQ:ARVN) reported second-quarter 2026 financial results and a corporate update that doubled as one of the more consequential updates in the company's history. The clinical-stage biotech disclosed the first-ever FDA approval
Read more
Report
Arvinas to Participate in Upcoming Investor Conferences
NEW HAVEN, Conn., Sept. 03, 2026 (GLOBE NEWSWIRE) -- Arvinas, Inc. (Nasdaq: ARVN) (
Read more
Report
Arvinas Sharpens Pipeline Focus After First PROTAC Approval, Eyes Key Trial Data
Detailed price information for Arvinas Inc (ARVN-Q) from The Globe and Mail including charting and trades.
Read more
Report
What Analysts Are Saying About Arvinas Stock
Arvinas (NASDAQ:ARVN) underwent analysis by 25 analysts in the last quarter, revealing a spectrum of viewpoints from bullish to bearish. In the table below, you'll find a summary of their recent ratings, revealing the shifting sentiments over the past 30.
Read more
Report
Arvinas Announces Late-Breaking Oral Presentation of Phase 3 VERITAC-2 Trial Results for Vepdegestrant at ASCO 2025
Arvinas will present Phase 3 VERITAC-2 trial results for vepdegestrant at ASCO 2025, evaluating its effectiveness in breast cancer treatment.
Read more
Report
Arvinas' inaugural commercial chief steps down, to be replaced in the interim by market access VP
Read more
Report
Arvinas And Novartis Partnering On Prostate Cancer Protein Degrader Is A Win-Win Situation
Read more
Report
Report
Show more news
Tech stack
Technologies named in job postings at Arvinas over the last 12 months, by layer, with the share of postings for each.
Technologies in use
1
Postings analysed
1
Stack modernity
64/100
Cloud & platforms
GCP
Sign in to see how your skills match this stack
Sign In
People
Sean Cassidy
Executive Officer
John Houston
Executive Officer, Director
Ian Taylor
Executive Officer
Andrew Levin
Director
Tim Shannon
Director
Kush Parmar
Director
Jakob Loven
Director
Liam Ratcliffe
Director
Stephen Squinto
Director
Jonathan Soderstrom
Director
Brad Margus
Director
Bradley Margus
Director
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove · How we handle this data
Growth
Hiring Momentum
29/100
Slowing
Open positions
1
0 opened / 1 closed in 30 days
Median time-to-fill
19 days
faster than 58% of the market
ATS activity
Every ~5 hours
Today
Hiring Dynamics
0%
Hiring Focus
The percentage next to each role is its share of the company's job openings over the last 90 days; the arrow shows the shift versus the previous period.
Science & Research
67% ▼
Biotech
33% ▲
Offices
Where the company hires and what each office is for
Cities
1
Hiring now
1
Countries
1
Busiest office
New Haven
New Haven
United States
HQ
New Haven - Headquarters
1 open roles 3 posted in 90 days 50-200 est. staff
hires for Biotech
395 Winchester Ave., New Haven, CT 06511
Jobs
Apply
Financials
Total raised
$1.1M
Latest round
Grant
Funding rounds
1
Funding rounds
| Round | Announced | Amount | |
|---|---|---|---|
| Grant | 2016 | $1.1M | Details |